CBMG
Cellular Biomedicine Group Inc
Price:
0
USD
Volume:
United States | Biotechnology
CBMG Gross Margin
As of 2025-07-14, the Gross Margin of Cellular Biomedicine Group Inc (CBMG) is 81.6%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
CBMG Gross Margin - Historical Value
| Date | Value |
|---|---|
| 2019-12-31 | 81.6% |
| 2018-12-31 | 39.5% |
| 2017-12-31 | 51.8% |
| 2016-12-31 | -37% |
| 2015-12-31 | 24.9% |
| 2014-12-31 | 62.2% |
| 2013-12-31 | -50% |
| 2012-12-31 | 29.6% |
| 2011-12-31 | 100% |
| 2010-12-31 | 100% |
CBMG Gross Margin - Peers Comparison